Find a Tender
complete
Official procurement procedure
NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
No classification published
Location not published
Published value
£5,400,000
Submission deadline 1 Jul 2026, 13:00 BST
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets". Published status: complete. Published value: £5,400,000. 1 published lot. Recorded submission deadline: 1 Jul 2026, 13:00 BST. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | Closed 1 Jul 2026, 13:00 BST |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £5,400,000 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published2 Sept 2026, 14:59 BST | Last source update2 Sept 2026, 14:59 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-0668c0 | ||
What is being bought
Project title: NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
Offer reference number: CM/TNS/26/5745
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5745 Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg
Lot 1 DNE, LNW & SOFE 1 November 2026 to 31 October 2027 (12 months)
Lot 2 DNW & MAE 1 November 2026 to 31 October 2027 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
What changed
From the official release history
- Official notice release published
2 Sept 2026, 14:59 BST - tender value changed
29 Jul 2026, 15:55 BST - Status changed to complete
29 Jul 2026, 15:55 BST - Official notice release published
29 Jul 2026, 15:55 BST - Submission deadline changed to published date
29 Jul 2026, 15:55 BST - Published value updated to £5,400,000
3 Jun 2026, 14:19 BST - Status changed to active
3 Jun 2026, 14:19 BST - Official notice release published
3 Jun 2026, 14:19 BST - Submission deadline changed to 1 Jul 2026, 13:00 BST
3 Jun 2026, 14:19 BST - Official notice release published
2 Apr 2026, 11:05 BST - Published value updated to £1,800,000
12 Mar 2026, 15:56 GMT - Status changed to planned
12 Mar 2026, 15:56 GMT - Official notice release published
12 Mar 2026, 15:56 GMT - Buyer information updated
12 Mar 2026, 15:56 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
2 Sept 2026, 14:59 BST - Submission deadline
1 Jul 2026, 13:00 BST - Award active
Not published · Not published - Contract active
Signed 12 Aug 2026, 00:00 BST · £8,545,000
Commercial outcome and competition
Awards Lupin Healthcare (UK) Limited, Merck Sharpe & Dohme (UK) Limited, Orifarm UK, Unicorn Pharmaceuticals Ltd Not published · Not published · active |
Contracts NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets £8,545,000 · signed 12 Aug 2026, 00:00 BST · active Contract period: 1 Nov 2026, 00:00 GMT — 31 Oct 2027, 23:59 GMT |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published